全文获取类型
收费全文 | 6811篇 |
免费 | 676篇 |
国内免费 | 450篇 |
专业分类
耳鼻咽喉 | 36篇 |
儿科学 | 101篇 |
妇产科学 | 167篇 |
基础医学 | 881篇 |
口腔科学 | 123篇 |
临床医学 | 879篇 |
内科学 | 1190篇 |
皮肤病学 | 66篇 |
神经病学 | 420篇 |
特种医学 | 349篇 |
外国民族医学 | 3篇 |
外科学 | 673篇 |
综合类 | 886篇 |
现状与发展 | 1篇 |
一般理论 | 2篇 |
预防医学 | 336篇 |
眼科学 | 145篇 |
药学 | 783篇 |
5篇 | |
中国医学 | 294篇 |
肿瘤学 | 597篇 |
出版年
2024年 | 28篇 |
2023年 | 113篇 |
2022年 | 274篇 |
2021年 | 361篇 |
2020年 | 287篇 |
2019年 | 266篇 |
2018年 | 272篇 |
2017年 | 218篇 |
2016年 | 179篇 |
2015年 | 341篇 |
2014年 | 382篇 |
2013年 | 342篇 |
2012年 | 537篇 |
2011年 | 548篇 |
2010年 | 317篇 |
2009年 | 234篇 |
2008年 | 293篇 |
2007年 | 349篇 |
2006年 | 329篇 |
2005年 | 390篇 |
2004年 | 193篇 |
2003年 | 187篇 |
2002年 | 152篇 |
2001年 | 113篇 |
2000年 | 131篇 |
1999年 | 124篇 |
1998年 | 103篇 |
1997年 | 88篇 |
1996年 | 90篇 |
1995年 | 64篇 |
1994年 | 79篇 |
1993年 | 37篇 |
1992年 | 62篇 |
1991年 | 56篇 |
1990年 | 48篇 |
1989年 | 54篇 |
1988年 | 42篇 |
1987年 | 42篇 |
1986年 | 27篇 |
1985年 | 23篇 |
1984年 | 21篇 |
1982年 | 13篇 |
1981年 | 11篇 |
1979年 | 11篇 |
1978年 | 17篇 |
1977年 | 7篇 |
1976年 | 10篇 |
1973年 | 10篇 |
1972年 | 6篇 |
1967年 | 7篇 |
排序方式: 共有7937条查询结果,搜索用时 0 毫秒
71.
Zhao P Cao J Zhao LJ Qin ZL Ke JS Pan W Ren H Yu JG Qi ZT 《第二军医大学学报》2006,27(5):506-506
The nucleocapsid (N) protein of SARS-coronavirus (SARS-CoV) is the key protein for the formation of the helical nucleocapsid during virion assembly. This protein is believed to be more conserved than other proteins of the virus, such as spike and membrane glycoprotein. In this study, the N protein of SARS-CoV was expressed in Escherichia coli DHSalpha and identified with pooled sera from patients in the convalescence phase of SARS. A plasmid pCI-N, encoding the full-length N gene of SARS-CoV, was constructed. Expression of the N protein was observed in COS1 cells following transfection with pCI-N. The immune responses induced by intramuscular immunization with pCI-N were evaluated in a murine model. Serum anti-N immunoglobutins and splenocytes proliferative responses against N protein were observed in immunized BALB/c mice. The major immunoglobulin G subclass recognizing N protein was immunoglobulin G2a, and stimulated splenocytes secreted high levels of gamma interferon and IL-2 in response to N protein. More importantly, the immunized mice produced strong delayed-type hypersensitivity (DTH) and CD^8+ CTL responses to N protein. 相似文献
72.
73.
74.
Interruption of the contrast column during inspiration can lead to non‐diagnostic CT pulmonary angiograms. The importance of this artefact will increase with more CT studies being performed for pulmonary embolism on multidetector row CT. We describe here an instance of such an artefact and discuss its aetiology. 相似文献
75.
We report a case of an assisted pregnancy in an asymptomatic woman who was found to have an extrauterine mass on ultrasound and MRI. This complex mass had equivocal imaging features and was found to be a ruptured ovarian ectopic pregnancy at surgery. This case illustrates that vigilance is required regarding the possibility of coexisting ectopic and intrauterine pregnancy following assisted conception, even in entirely asymptomatic cases. 相似文献
76.
西替利嗪凝胶的制备和质量评价 总被引:1,自引:0,他引:1
目的:制备西替利嗪凝胶剂,并建立质量控制方法.方法:以卡波姆940为基质制备凝胶,采用紫外分光光度法测定西替利嗪含量,并考察其稳定性.结果:西替利嗪线性范围为6~16 mg·L-1(r=0.996 7),平均回收率为98.23%,RSD为0.69%(n=5),凝胶稳定性良好.结论:该凝胶制备工艺可行,性质稳定. 相似文献
77.
Ying Fu Rengui Saxu Kadir Ahmad Ridwan Cai Zhao Xiangshun Kong Yao Rong Weida Zheng Peng Yu Yuou Teng 《RSC advances》2022,12(34):21821
Axitinib is a potent vascular endothelial growth factor receptor (VEGFR) inhibitor, which has a strong inhibitory effect on the three isoforms of VEGFR 1–3. Having strong therapeutic efficacy, its broad use is limited by its side effects such as hypertension, proteinuria, cardiovascular damage, and liver and kidney dysfunction. Selenium compounds are broadly reported to have a good protective effect on cardiovascular disease, inflammation, infection, and immune function. In this study, a selenium substitute of axitinib was synthesized, and its anti-renal cell carcinoma activity and side effects were investigated. The results of the study indicated that Se-axitinib had potent antitumor activity on renal cell carcinoma (RCC), alleviated vascular hyperpermeability, and also alleviated axitinib-related side effects including hypertension, liver dysfunction and kidney dysfunction significantly. Therefore, we suggest that Se-axitinib could be a solution to the severe side effects of VEGFR inhibitors and provide evidence to improve the outcome of RCC treatment.Se-axitinib is a selenium substitution of sulfur in axitinib, which reduced the side effect of VEGFR inhibitors and maintained the potent anticancer activity of the original drug. 相似文献
78.
医学教育改革更多的是热衷于授课形式和方法的改革,而忽视了真正能够渗透到教学各方面的教学理念的改革。结合对生理学教学目标的反思和“岗位胜任力”培养的需求,将生理学教学的核心理念总结为四个方面:“三观”要正,帮助学生树立平衡观、辩证观和整体观;“三基”要牢,培养学生掌握基本的知识架构体系、基本的知识获取能力、基本的操作技能;重视学以致用和强化人文素养。上述核心理念在教学实践中得到学生的广泛认可,临床医学专业学生对核心理念的评价明显高于护理专业。下一步教学改革的方向是在教学理念的指导下如何细化授课内容,以适应专业设置越来越细化的现状。 相似文献
79.
Yu Liu Hui Wang Xiao-Yi Yin Teng Wang Jiong Liu Lin Wu Liang-Hao Hu Fang-Yu Wang 《The Journal of international medical research》2022,50(5)
Endoscopic mucosal resection (EMR) was originally described in 1973 and is currently a popular practice used in treating polyps, small adenomas, and early cancers. Although the safety of EMR has been proven in numerous studies, complications occur occasionally. We report a case in which the patient complained of severe upper abdominal pain and who was diagnosed with acute appendicitis after colorectal EMR. The patient recovered well after surgery. Cautious observation is necessary when resuming oral intake in patients who undergo colorectal EMR and who complain of postoperative abdominal pain. Observation is especially important for patients with a fecalith that may have originally existed in the appendix or in the colon near the appendix. 相似文献
80.
Nicole-Ann Lim Ooiean Teng Chester Yan Hao Ng Lena X. Y. Bao Paul Anantharajah Tambyah Amy M. L. Quek Raymond C. S. Seet 《Annals of medicine》2022,54(1):1488
BackgroundAccumulating data suggest antiviral effects of povidone-iodine against the Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus. This narrative review aims to examine the antiviral mechanisms of povidone-iodine, efficacy of povidone-iodine against the SARS-CoV-2 virus, and safety of povidone-iodine to human epithelial cells and thyroid function.MethodsWe searched the electronic databases PubMed, Embase, Cochrane Library, ClinicalTrials.gov and World Health Organization’s International Clinical Trials Registry Platform for articles containing the keywords “povidone-iodine”, “SARS-CoV-2” and “COVID-19” from database inception till 3 June 2021.ResultsDespite in vitro data supporting the anti-SARS-CoV-2 effects of povidone-iodine, findings from clinical studies revealed differences in treatment response depending on study settings (healthy vs. hospitalized individuals), treatment target (nasal vs. oral vs. pharynx), method of administration (oral rinse vs. gargle vs. throat spray) and choice of samples used to measure study endpoints (nasopharyngeal vs. saliva). One large-scale clinical trial demonstrated reduction in the incidence of SARS-CoV-2 infection among participants who administered povidone-iodine 3 times daily during an active outbreak. Povidone-iodine is also used to disinfect the oro-pharyngeal space prior to dental or otolaryngology procedures. Although existing data suggest minimal impact of povidone-iodine on thyroid function, high-quality safety data are presently lacking.ConclusionsPovidone-iodine application to the oropharyngeal space could complement existing non-pharmacological interventions to reduce SARS-CoV-2 infection especially in high exposure settings.
Key messages
- Accumulating data suggest antiviral effects of povidone-iodine against the SARS-CoV-2 virus.
- Findings from clinical studies reveal differences in treatment response depending on study settings, treatment target, method of administration and choice of samples used to measure study endpoints. One large-scale clinical trial observed reduction in the incidence of SARS-CoV-2 infection among participants who administered povidone-iodine 3 times daily during an active outbreak.
- Povidone-iodine application to the oropharyngeal space could complement existing non-pharmacological interventions to reduce SARS-CoV-2 infection especially in high exposure settings.